logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
N

Neil Ahluwalia

Vertex Pharmaceuticals
H指数:25
被引数:4,129

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Effects of Elexacaftor/Tezacaftor/Ivacaftor on cough frequency, physical activity patterns, and sleep quality in adolescents and adults with cystic fibrosis

Elexacaftor/Tezacaftor/Ivacaftor对囊性纤维化青少年和成人患者咳嗽频率、身体活动模式及睡眠质量的影响

Journal of Cystic Fibrosis
IF6
2026-03-310
OAAI
Eva Van Braeckel; Andrew T. Braun; Nicholas J. Simmonds; Peter J. Barry; Jane C. Davies; Marie E. Egan; Allen Lapey; Marcus A. Mall; Edward F. McKone; Daniel Peckham; Marijke Proesmans; Bonnie Ramsey; Saioa Vicente Santamaria; Daniel Smith; Jennifer L. Taylor-Cousar; Elizabeth Tullis; Elke De Wachter; Nick Withers; Neil Ahluwalia; Sarah Conner
Long-term safety and efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis and at least one F508del allele: 144-week interim results from a 192-week open-label extension study
EUROPEAN RESPIRATORY JOURNAL
IF21
2023-11-0921
OAAI
Daines, Cori L.; Tullis, Elizabeth; Costa, Stefano; Linnemann, Rachel W.; Mall, Marcus A.; McKone, Edward F.; Polineni, Deepika; Quon, Bradley S.; Ringshausen, Felix C.; Rowe, Steven M.; Selvadurai, Hiran; Taylor-Cousar, Jennifer L.; Withers, Nicholas J.; Ahluwalia, Neil; Moskowitz, Samuel M.; Prieto-Centurion, Valentin; Tan, Yaoyuan Vincent; Tian, Simon; Weinstock, Tanya; Xuan, Fengjuan; Zhang, Yaohua; Ramsey, Bonnie; Griese, Matthias
Long-Term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged ≥6 Years with Cystic Fibrosis and at Least One F508del Allele A Phase 3, Open-Label Clinical Trial
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
IF19.4
2023-07-0122
OA
Wainwright, Claire; McColley, Susanna A.; McNally, Paul; Powers, Michael; Ratjen, Felix; Rayment, Jonathan H.; Retsch-Bogart, George; Roesch, Erica; Ahluwalia, Neil; Chin, Anna; Chu, Chenghao; Lu, Mengdi; Menon, Prema; Waltz, David; Weinstock, Tanya; Zelazoski, Laura; Davies, Jane C.
Phase 3 Open-Label Clinical Trial of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged 2-5 Years with Cystic Fibrosis and at Least One F508del Allele
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
IF19.4
2023-07-0150
OAAI
Goralski, Jennifer L.; Hoppe, Jordana E.; Mall, Marcus A.; McColley, Susanna A.; McKone, Edward; Ramsey, Bonnie; Rayment, Jonathan H.; Robinson, Phil; Stehling, Florian; Taylor-Cousar, Jennifer L.; Tullis, Elizabeth; Ahluwalia, Neil; Chin, Anna; Chu, Chenghao; Lu, Mengdi; Niu, Tao; Weinstock, Tanya; Ratjen, Felix; Rosenfeld, Margaret
Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 Through 11 Years of Age with Cystic Fibrosis Heterozygous for F508del and a Minimal Function Mutation A Phase 3b, Randomized, Placebo-controlled Study
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
IF19.4
2022-12-0162
OAAI
Mall, Marcus A.; Brugha, Rossa; Gartner, Silvia; Legg, Julian; Moeller, Alexander; Mondejar-Lopez, Pedro; Prais, Dario; Pressler, Tacjana; Ratjen, Felix; Reix, Philippe; Robinson, Paul D.; Selvadurai, Hiran; Stehling, Florian; Ahluwalia, Neil; Arteaga-Solis, Emilio; Bruinsma, Bote G.; Jennings, Mark; Moskowitz, Samuel M.; Noel, Sabrina; Tian, Simon; Weinstock, Tanya G.; Wu, Pan; Wainwright, Claire E.; Davies, Jane C.
A Phase 3, open-label, 96-week trial to study the safety, tolerability, and efficacy of tezacaftor/ivacaftor in children ≥ 6 years of age homozygous for F508del or heterozygous for F508del and a residual function CFTR variant
JOURNAL OF CYSTIC FIBROSIS
IF6
2022-07-018
OAAI
Sawicki, Gregory S.; Chilvers, Mark; McNamara, John; Naehrlich, Lutz; Saunders, Clare; Sermet-Gaudelus, Isabelle; Wainwright, Claire E.; Ahluwalia, Neil; Campbell, Daniel; Harris, R. Scott; Paz-Diaz, Hildegarde; Shih, Judy L.; Davies, Jane C.
Triple Therapy for Cystic Fibrosis Phe508del-Gating and -Residual Function Genotypes
NEW ENGLAND JOURNAL OF MEDICINE
IF78.5
2021-08-26168
OA
Barry, Peter J.; Mall, Marcus A.; Alvarez, Antonio; Colombo, Carla; de Winter-de Groot, Karin M.; Fajac, Isabelle; McBennett, Kimberly A.; McKone, Edward F.; Ramsey, Bonnie W.; Sutharsan, Sivagurunathan; Taylor-Cousar, Jennifer L.; Tullis, Elizabeth; Ahluwalia, Neil; Jun, Lucy S.; Moskowitz, Samuel M.; Prieto-Centurion, Valentin; Tian, Simon; Waltz, David; Xuan, Fengjuan; Zhang, Yaohua; Rowe, Steven M.; Polineni, Deepika
Long-term safety and efficacy of tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study
LANCET RESPIRATORY MEDICINE
IF32.8
2021-07-0136
OAAI
Flume, Patrick A.; Biner, Reta Fischer; Downey, Damian G.; Brown, Cynthia; Jain, Manu; Fischer, Rainald; De Boeck, Kris; Sawicki, Gregory S.; Chang, Philip; Paz-Diaz, Hildegarde; Rubin, Jaime L.; Yang, Yoojung; Hu, Xingdi; Pasta, David J.; Millar, Stefanie J.; Campbell, Daniel; Wang, Xin; Ahluwalia, Neil; Owen, Caroline A.; Wainwright, Claire E.
A Phase 3 Open-Label Study of Elexacaftor/Tezacaftor/lvacaftor in Children 6 through 11 Years of Age with Cystic Fibrosis and at Least One F508del Allele
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
IF19.4
2021-06-15156
OAAI
Zemanick, Edith T.; Taylor-Cousar, Jennifer L.; Davies, Jane; Gibson, Ronald L.; Mall, Marcus A.; McKone, Edward F.; McNally, Paul; Ramsey, Bonnie W.; Rayment, Jonathan H.; Rowe, Steven M.; Tullis, Elizabeth; Ahluwalia, Neil; Chu, Chenghao; Ho, Thang; Moskowitz, Samuel M.; Noel, Sabrina; Tian, Simon; Waltz, David; Weinstock, Tanya G.; Xuan, Fengjuan; Wainwright, Claire E.; McColley, Susanna A.
A phase 3, double-blind, parallel-group study to evaluate the efficacy and safety of tezacaftor in combination with ivacaftor in participants 6 through 11 years of age with cystic fibrosis homozygous for F508del or heterozygous for the F508del-CFTR mutation and a residual function mutation
JOURNAL OF CYSTIC FIBROSIS
IF6
2021-01-0147
OAAI
Davies, Jane C.; Sermet-Gaudelus, Isabelle; Naehrlich, Lutz; Harris, R. Scott; Campbell, Daniel; Ahluwalia, Neil; Short, Christopher; Haseltine, Eric; Panorchan, Paul; Saunders, Clare; Owen, Caroline A.; Wainwright, Claire E.
Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial
LANCET
IF88.5
2019-11-01858
OAAI
Heijerman, Harry G. M.; McKone, Edward F.; Downey, Damian G.; Van Braeckel, Eva; Rowe, Steven M.; Tullis, Elizabeth; Mall, Marcus A.; Welter, John J.; Ramsey, Bonnie W.; Mckee, Charlotte M.; Marigowda, Gautham; Moskowitz, Samuel M.; Waltz, David; Sosnay, Patrick R.; Simard, Christopher; Ahluwalia, Neil; Xuan, Fengjuan; Zhang, Yaohua; Taylor-Cousar, Jennifer L.; Mccoy, Karen S.
ADAM10-mediated ephrin-B2 shedding promotes myofibroblast activation and organ fibrosis (vol 23, pg 1405, 2017)
NATURE MEDICINE
IF50
2017-12-014
OAAI
Lagares, David; Ghassemi-Kakroodi, Parisa; Tremblay, Caroline; Santos, Alba; Probst, Clemens K.; Franklin, Alicia; Santos, Daniela M.; Grasberger, Paula; Ahluwalia, Neil; Montesi, Sydney B.; Shea, Barry S.; Black, Katharine E.; Knipe, Rachel; Blati, Meryem; Baron, Murray; Wu, Brian; Fahmi, Hassan; Gandhi, Rajiv; Pardo, Annie; Selman, Moises; Wu, Jiangping; Pelletier, Jean-Pierre; Martel-Pelletier, Johanne; Tager, Andrew M.; Kapoor, Mohit
ADAM10-mediated ephrin-B2 shedding promotes myofibroblast activation and organ fibrosis
NATURE MEDICINE
IF50
2017-10-23109
OAAI
Lagares, David; Ghassemi-Kakroodi, Parisa; Tremblay, Caroline; Santos, Alba; Probst, Clemens K.; Franklin, Alicia; Santos, Daniela M.; Grasberger, Paula; Ahluwalia, Neil; Montesi, Sydney B.; Shea, Barry S.; Black, Katharine E.; Knipe, Rachel; Blati, Meryem; Baron, Murray; Wu, Brian; Fahmi, Hassan; Gandhi, Rajiv; Pardo, Annie; Selman, Moises; Wu, Jiangping; Pelletier, Jean-Pierre; Martel-Pelletier, Johanne; Tager, Andrew M.; Kapoor, Mohit

研究方向

暂未获取到该数据
M
Marcus Mall
H 指数:82论文数:1,218被引数:2.6万
A
Andrew M. Tager
H 指数:67论文数:172被引数:1.6万
C
Claire Wainwright
H 指数:53论文数:362被引数:1.3万
E
Elizabeth Tullis
H 指数:59论文数:351被引数:1.7万
J
Jane C. Davies
H 指数:68论文数:766被引数:2.3万
J
Jennifer L. Taylor‐Cousar
H 指数:44论文数:225被引数:1.1万
E
Edward F. McKone
H 指数:32论文数:110被引数:7,822
D
Daniel Campbell
H 指数:11论文数:36被引数:1,114
T
Tanya G. Weinstock
H 指数:11论文数:41被引数:1,230
S
Steven M. Rowe
H 指数:71论文数:434被引数:2.9万